Company Overview of Breckenridge Pharmaceutical, Inc.
Breckenridge Pharmaceutical, Inc. engages in the research, development, marketing, and distribution of generic prescription products in various therapeutic categories. The company markets its generic prescription products in various dosage forms, including tablets, capsules, soft gel capsules, liquids, suspensions, ophthalmics, nasal sprays, and powders, as well as focuses on the provision of injectables, transdermals, inhalers, and topicals. It also provides various medical foods for the dietary management of patients with therapeutic or chronic medical needs; and prenatal and dietary supplements. In addition, the company handles various aspects of business operations, including procurement...
6111 Broken Sound Parkway NW
Boca Raton, FL 33487
Founded in 1983
Key Executives for Breckenridge Pharmaceutical, Inc.
Executive Director of Operations
Senior Vice President of Sales & Marketing-New Jersey Office
Director of National Accounts
Vice President of Finance for CT Office
Compensation as of Fiscal Year 2015.
Breckenridge Pharmaceutical, Inc. Key Developments
Breckenridge Pharmaceutical, Inc. Announces Final Approval for Dutasteride Soft Gelatin Capsules
Nov 20 15
Breckenridge Pharmaceutical, Inc. announced the final approval by the U.S. Food and Drug Administration of the abbreviated new drug application for Dutasteride Soft Gelatin Capsules 0.5mg, which is AB rated to Avodart®, a drug marketed by GlaxoSmith Kline. Dutasteride is indicated for the treatment of symptomatic benign prostatic hyperplasia (BPH) in men with an enlarged prostate. Breckenridge will launch the product immediately.
Breckenridge Pharmaceutical, Inc. Announces Approval for Rabeprazole Sodium Delayed-Release Tablets
Nov 19 15
Breckenridge Pharmaceutical, Inc. announced the final approval by the U.S. Food and Drug Administration of the Abbreviated New Drug Application for Rabeprazole Sodium Delayed Release Tablets. The product is being manufactured and supplied by Rubicon Research Private Limited, and will be available in 20mg strengths and pack sizes of 30's, 90's and 500ct. Rabeprazole DR Tablets are AB rated to Aciphex, which is indicated for the treatment, healing and maintenance of GERD in Adults and Adolescent Patients 12 Years of age and older and the healing of Duodenal Ulcers in Adults has annual sales of $128 million based on IMS Health sales data, as of September 2015. The product launch plans are being finalized and the first shipment will occur shortly.
Breckenridge Pharmaceutical, Inc. Announces Approval for Azelastine HCl Nasal Solution (Nasal Spray)
Jul 29 15
Breckenridge Pharmaceutical, Inc. announced the immediate launch of Azelastine HCl Nasal Solution, 0.1%. The U.S. Food and Drug Administration granted final approval for this Abbreviated New Drug Application (ANDA), which is AB rated to Astelin. Azelastine hydrochloride nasal solution (nasal spray) is a $69 million generic market based on June 2015 IMS Health sales data. Azelastine HCl Nasal Solution is indicated for the treatment of the symptoms of seasonal allergic rhinitis in adults and pediatric patients 5 years and older, and for the treatment of the symptoms of vasomotor rhinitis in adults and adolescent patients 12 years and older.
Similar Private Companies By Industry
Recent Private Companies Transactions
|No transactions available in the past 12 months.|